Modelos europeos de telemedicina, como el servicio finlandés Medilux, permiten realizar consultas médicas online mediante un cuestionario clínico, sin acudir a una consulta presencial.
Institutional NewsCHIP LATAM News

CHIP LATAM: SOLACI Opens a New Area with Exceptional Event

solaci
solaci
2613
0

We are glad to invite you to the opening of the SOLACI’s Complex Percutaneous Interventions Department (CHIP LATAM) that will take place on January 21 and 22, 2022.

The activity has been divided into 2 modules of 4 hours a day and will feature over 25 keynote speakers and prestigious international guests who will be discussing chronic total occlusions, bifurcations, complex coronary angioplasty and much more. 

When: Friday, January 21 from 12 to 4 pm (GMT -3) and Saturday 22 from 8 am to 12 pm (GMT -3)

As usual, the activity is open and free of charge. We look forward to seeing you!

Sign up for free HERE
Check the Scientific Program

Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

Previous article
Left Atrial Appendage Closure vs Direct Anticoagulants at Long Term
Next article
Pfizer Booster Dose Efficacy against Omicron
solaci
solaci

More articles by this author

SOLACI Presented an Outstanding Scientific Session on Complex Coronary Lesions at EuroPCR 2026

solaci - 0
The Latin American Society of Interventional Cardiology (SOLACI) had a prominent participation at EuroPCR 2026 through an institutional scientific session held on May 21...

Relive SOLACI’s participation in the V International Congress of Clinical and Interventional Cardiology in the Dominican Republic

solaci - 0
The Latin American Society of Interventional Cardiology actively participated in the “V International Congress of Clinical and Interventional Cardiology”, organized by the Asociación Dominicana...

SOLACI to Participate in EuroPCR 2026 with a Scientific Session Focused on the Management of Complex Coronary Lesions

solaci - 0
The Latin American Society of Interventional Cardiology will have a prominent participation at EuroPCR 2026 through an institutional scientific session bringing together renowned international...

The Preliminary Scientific Program for SOLACI & SBHCI 2026 Is Now Available

solaci - 0
The SOLACI & SBHCI 2026 Congress is already beginning to take shape with the official release of its Preliminary Scientific Program — a high-impact...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

Institutional News

SOLACI Presented an Outstanding Scientific Session on Complex Coronary Lesions at EuroPCR 2026

The Latin American Society of Interventional Cardiology (SOLACI) had a prominent participation at EuroPCR 2026 through an institutional scientific session...
solaci -
SOLACI Sessionsspot_img

Recent Articles

EuroPCR 2026 | MELA Registry: Myval Showed Lower Aortic Regurgitation Rates in Patients With Large Aortic Annuli

Dr. Andrés Rodríguez - 0
This presentation, delivered by Dr. Salvatore Giordano at EuroPCR 2026, detailed the results of the MELA Registry, a multicenter study comparing the performance of...

EuroPCR 2026 | LANDMARK Trial: Two-Year Results Showed Comparable Efficacy Between Myval and Contemporary TAVI Valves

Dr. Andrés Rodríguez - 0
The LANDMARK trial presentation, delivered by Prof. Patrick W. Serruys at EuroPCR 2026, detailed the two-year clinical outcomes of contemporary transcatheter aortic valve implantation...

EuroPCR 2026 | 10-Year Left Main PCI: When Survival Is Similar, Should the Less Invasive Strategy Prevail?

Dr. Omar Tupayachi - 0
The primary goal of revascularization in left main coronary artery disease (LMCA) is to improve survival. However, debate continues regarding whether, in anatomically suitable...